Immunohistochemistry CEA Carcinoembryonic Antigen Test
Comprehensive Cancer Diagnostic Testing
The Immunohistochemistry CEA Carcinoembryonic Antigen Test represents a cornerstone in modern cancer diagnostics, providing critical insights into tumor characteristics and behavior. This sophisticated laboratory procedure utilizes advanced immunohistochemical techniques to detect and quantify CEA protein expression within tissue samples, offering invaluable information for cancer diagnosis, staging, and treatment planning.
What Does This Test Measure?
This specialized test precisely measures the presence and distribution of Carcinoembryonic Antigen (CEA) within tumor tissue samples. CEA is a glycoprotein that typically appears during fetal development but becomes reactivated in various cancer types. The test employs specific antibodies that bind to CEA proteins, creating visible staining patterns that pathologists can analyze under microscopy to determine:
- CEA protein expression levels and distribution patterns
- Tumor cell differentiation and origin characteristics
- Potential metastatic behavior and aggressiveness indicators
- Response markers for targeted therapy considerations
Who Should Consider This Test?
This diagnostic test is particularly recommended for individuals experiencing:
- Unexplained weight loss, persistent fatigue, or appetite changes
- Abnormal bleeding, digestive disturbances, or bowel habit changes
- Suspicious masses detected through imaging studies
- Family history of colorectal, lung, or gastrointestinal cancers
- Previous cancer diagnosis requiring treatment monitoring
- Pre-operative evaluation for suspected malignancies
- Post-treatment surveillance and recurrence monitoring
Clinical Benefits and Applications
The Immunohistochemistry CEA Test provides numerous clinical advantages:
- Accurate Cancer Diagnosis: Helps confirm malignancy and identify tumor origins
- Treatment Guidance: Assists oncologists in selecting appropriate therapeutic approaches
- Prognostic Information: Provides insights into disease progression and potential outcomes
- Monitoring Capabilities: Enables tracking of treatment response and disease recurrence
- Personalized Medicine: Supports development of targeted treatment strategies
Understanding Your Test Results
Test results are typically categorized based on staining intensity and distribution patterns:
- Positive Result: Indicates CEA protein expression, commonly associated with adenocarcinomas of colorectal, lung, breast, or gastrointestinal origin
- Negative Result: Suggests absence of significant CEA expression, potentially indicating different tumor types
- Focal vs. Diffuse Patterns: Distribution patterns provide additional diagnostic information
- Staining Intensity: The strength of staining correlates with protein expression levels
Your healthcare provider will interpret these results within the context of your clinical presentation, imaging findings, and other diagnostic information to develop a comprehensive understanding of your condition.
Test Pricing and Availability
| Test Name | Discount Price | Regular Price |
|---|---|---|
| Immunohistochemistry CEA Carcinoembryonic Antigen Test | $76 USD | $112 USD |
Sample Requirements and Processing
For optimal results, please provide:
- Tumor tissue preserved in 10% formal-saline solution
- Formalin-fixed paraffin-embedded tissue blocks
- Complete histopathology report copy
- Detailed biopsy site information
- Comprehensive clinical history documentation
Samples are accepted daily until 6:00 PM, with standard processing times of 5 days for blocks and tissue biopsies, and 7 days for large complex tissue specimens.
Nationwide Accessibility
We maintain comprehensive testing facilities across the United States, with convenient locations in all major metropolitan areas including New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, and San Jose. Our network ensures timely sample processing and result delivery regardless of your location.
Take Control of Your Health Today
Don’t delay critical cancer diagnostics. Our experienced team of oncologists and pathologists are ready to provide you with accurate, reliable testing services. For immediate assistance or to schedule your test, contact our dedicated healthcare professionals at +1(267) 388-9828 or book your appointment online through our secure patient portal.
Early detection and accurate diagnosis are essential components of successful cancer management. Trust General Genetics Corporation for your diagnostic needs and take the first step toward comprehensive cancer care.
